Celyad SA Skyrocketed

Mon, Aug 01, 2022 at 06:47 PM
Celyad SA Skyrocketed

Celyad SA (CYAD:NASDAQ) shot up at $2.45, representing a gain of 40.8%. On Mon, Aug 01, 2022, CYAD:NASDAQ touched a New 2-Week High of $2.45. The stock appeared on our News Catalysts scanner on Mon, Aug 01, 2022 at 09:41 AM in the 'BIOTECH' category. From Mon, Jul 18, 2022, the stock recorded 50.00% Up Days and 22.22% Green Days

About Celyad SA (CYAD:NASDAQ)

Celyad SA is a biopharmaceutical company. The company is engaged in stem cell-based therapies for the treatment of cardiovascular diseases. It is developing therapeutic therapies based on two distinct technology platforms in cardiology and oncology.

Share
Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.